Outcome | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Exposure | All lymphomas(ca = 50 615/co = 92 928) | NHL(ca = 32 773/co = 60 202) | HL(ca = 7161/co = 13 103) | CLL(ca = 10 982/co = 20 141) | ||||||||
ca | co | OR (95% CI) | ca | co | OR (95% CI) | ca | co | OR (95% CI) | ca | co | OR (95% CI) | |
AS, ankylosing spondylitis; ca, cases; CLL, chronic lymphocytic leukaemia; co, controls; HL, Hodgkin’s lymphoma; NHL, non-Hodgkin’s lymphoma. | ||||||||||||
Data are stratified by lymphoma type, including all lymphomas. | ||||||||||||
Personalhistoryof AS | 23 | 41 | 1.0 (0.6 to 1.7) | 15 | 33 | 0.8 (0.4 to 1.5) | 2 | 2 | 1.7 (0.2 to 12) | 6 | 6 | 1.9 (0.6 to 5.9) |